CUSHMAN & WAKEFIELD PLC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.18 USD | -0.20% |
|
+5.49% | -5.74% |
| Apr. 29 | Cushman & Wakefield Reports No Adjusted Profit or Loss in Q1, Revenue Declines | MT |
| Apr. 29 | Transcript : Cushman & Wakefield plc, Q1 2024 Earnings Call, Apr 29, 2024 |
Summary
- The company presents an interesting fundamental situation from a short-term investment perspective.
Strengths
- The earnings growth currently anticipated by analysts for the coming years is particularly strong.
- The stock, which is currently worth 2024 to 0.49 times its sales, is clearly overvalued in comparison with peers.
- Upward revisions of sales forecast reflect a renewed optimism among the analysts covering the stock.
- For the last few months, EPS revisions have remained quite promising. Analysts now anticipate higher profitability levels than before.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- Over the past twelve months, analysts' opinions have been strongly revised upwards.
Weaknesses
- According to forecast, a sluggish sales growth is expected for the next fiscal years.
- The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
- Low profitability weakens the company.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
- The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Real Estate Services
| 1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
|---|---|---|---|---|
| -5.74% | 2.34B | C+ | ||
| -7.08% | 26.09B | B+ | ||
| +1.60% | 20.4B | C- | ||
| -18.67% | 9.73B | B- | ||
| +1.18% | 9.05B | B+ | ||
| -3.34% | 6.78B | C- | ||
| -9.91% | 5.64B | B+ | ||
| +53.16% | 5.03B | - | - | |
| -16.21% | 2.2B | C | ||
| +100.46% | 2.18B | - | - |
Investor Rating
Trading Rating
ESG Refinitiv
Financials
Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances
Valuation
P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield
-
Momentum
1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision
Consensus
Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion
Business Predictability
Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality
Environment
Emissions
Innovation
Use of resources
Governance
CSR Strategy
Management
Shareholders
Controversy
Controversy
Technical analysis
ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
- Stock Market
- Equities
- CWK Stock
- Ratings Cushman & Wakefield plc